• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡瑞利珠单抗诱导的孤立性展神经炎:一种罕见的眼部免疫相关不良事件。

Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events.

作者信息

Hou Yanli, Su Qiang, Tang Simeng, Li Hongyang

机构信息

Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

出版信息

Brain Sci. 2022 Sep 14;12(9):1242. doi: 10.3390/brainsci12091242.

DOI:10.3390/brainsci12091242
PMID:36138977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9496756/
Abstract

BACKGROUND

Anti-tumor immunotherapy with immune checkpoint inhibitors induces several immune-related adverse events. Camrelizumab-related isolate abducens neuritis is rare.

CASE PRESENTATION

We report on a 67-year-old man with esophageal cancer who presented with acute-onset isolated right abducens cranial nerve palsy after ten cycles of Camrelizumab treatment. Magnetic resonance imaging examination revealed thickening and post-contrast enhancement at the cisternal segment of the right abducens nerve. The diagnosis was immune-related abducens neuritis caused by Camrelizumab. We put him on oral taper corticoids (methylprednisone) for neuritis treatment without Camrelizumab suspension. One month after treatment, he recovered completely. At the last follow-up, one year after the onset of diplopia, the patient was in good condition without neurological symptom recurrence.

CONCLUSION

Abducens neuritis is a rare immune-related adverse outcome of Camrelizumab. The present case proves the efficacy and safety of using corticoids in the treatment of abducens neuritis.

摘要

背景

使用免疫检查点抑制剂进行抗肿瘤免疫治疗会引发多种免疫相关不良事件。卡瑞利珠单抗相关的孤立性展神经神经炎较为罕见。

病例报告

我们报告了一名67岁的食管癌男性患者,在接受十个周期的卡瑞利珠单抗治疗后出现急性起病的孤立性右侧展神经麻痹。磁共振成像检查显示右侧展神经脑池段增粗且增强扫描有强化。诊断为卡瑞利珠单抗所致的免疫相关展神经神经炎。我们给予他口服逐渐减量的皮质类固醇(甲泼尼龙)治疗神经炎,未停用卡瑞利珠单抗。治疗一个月后,他完全康复。在复视发作一年后的最后一次随访中,患者状况良好,无神经症状复发。

结论

展神经神经炎是卡瑞利珠单抗罕见的免疫相关不良后果。本病例证明了使用皮质类固醇治疗展神经神经炎的有效性和安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/8ecbc3213472/brainsci-12-01242-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/7d437e271fbe/brainsci-12-01242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/e43b3ed6e5be/brainsci-12-01242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/b21aa55c40b9/brainsci-12-01242-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/acb395d95862/brainsci-12-01242-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/8ecbc3213472/brainsci-12-01242-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/7d437e271fbe/brainsci-12-01242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/e43b3ed6e5be/brainsci-12-01242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/b21aa55c40b9/brainsci-12-01242-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/acb395d95862/brainsci-12-01242-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b62/9496756/8ecbc3213472/brainsci-12-01242-g005.jpg

相似文献

1
Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events.卡瑞利珠单抗诱导的孤立性展神经炎:一种罕见的眼部免疫相关不良事件。
Brain Sci. 2022 Sep 14;12(9):1242. doi: 10.3390/brainsci12091242.
2
A case report of the diagnosis and treatment of immune checkpoint inhibitor-related encephalitis induced by camrelizumab.卡瑞利珠单抗诱导的免疫检查点抑制剂相关脑炎的诊断与治疗病例报告
AME Case Rep. 2024 Sep 6;8:101. doi: 10.21037/acr-24-58. eCollection 2024.
3
Rare Combination of Abducens Nerve Palsy and Optic Neuritis on the Same Side: Case Report and Review of 8 Patients in Literature.同一侧展神经麻痹和视神经炎的罕见组合:病例报告及文献复习 8 例
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096231225873. doi: 10.1177/23247096231225873.
4
Neurosyphilis Presenting with Isolated Abducens Nerve Palsy.以孤立性展神经麻痹为表现的神经梅毒
Intern Med. 2025 Mar 15;64(6):917-919. doi: 10.2169/internalmedicine.4098-24. Epub 2024 Aug 8.
5
Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature.卡瑞利珠单抗相关免疫检查点抑制剂肺炎:病例报告及文献复习。
Ann Palliat Med. 2021 Jul;10(7):8460-8466. doi: 10.21037/apm-21-23. Epub 2021 May 12.
6
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎:一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
7
Idiopathic third and sixth cranial nerve neuritis.特发性动眼神经和展神经神经炎
Jpn J Ophthalmol. 2019 Jul;63(4):337-343. doi: 10.1007/s10384-019-00666-7. Epub 2019 Apr 20.
8
Abducens nerve palsy associated with pseudomeningocele after lumbar disc surgery: a case report.展神经麻痹伴腰椎间盘手术后假性脑脊膜膨出:一例报告。
Spine (Phila Pa 1976). 2012 Apr 15;37(8):E511-3. doi: 10.1097/BRS.0b013e3182373b95.
9
[Isolated abducens nerve palsy caused by pontine infarction].[桥脑梗死所致孤立性外展神经麻痹]
Rinsho Shinkeigaku. 1992 May;32(5):541-2.
10
Successful oral treatment of third cranial nerve palsy and optic neuritis from neglected herpes zoster in an immunocompetent patient.免疫功能正常患者中,成功通过口服药物治疗由隐匿性带状疱疹引起的动眼神经麻痹和视神经炎。
Am J Ophthalmol Case Rep. 2020 Oct 1;20:100953. doi: 10.1016/j.ajoc.2020.100953. eCollection 2020 Dec.

引用本文的文献

1
Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients.免疫检查点抑制剂相关的颅神经受累:对136例患者的系统文献综述
J Neurol. 2024 Oct;271(10):6514-6525. doi: 10.1007/s00415-024-12660-2. Epub 2024 Sep 3.

本文引用的文献

1
Camrelizumab-Related Myocarditis and Myositis With Myasthenia Gravis: A Case Report and Literature Review.卡瑞利珠单抗相关的心肌炎、肌炎合并重症肌无力:1例病例报告及文献综述
Front Oncol. 2022 Jan 3;11:778185. doi: 10.3389/fonc.2021.778185. eCollection 2021.
2
Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review.免疫性心肌炎重叠重症肌无力:一例接受抗 PD-1 治疗脊索瘤患者的病例报告及文献复习。
Front Immunol. 2021 Jul 8;12:682262. doi: 10.3389/fimmu.2021.682262. eCollection 2021.
3
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials.
程序性死亡-1通路抑制剂在晚期胃食管癌中的疗效和安全性比较:一项III期临床试验的系统评价和网状Meta分析
Cancers (Basel). 2021 May 26;13(11):2614. doi: 10.3390/cancers13112614.
4
Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature.卡瑞利珠单抗相关免疫检查点抑制剂肺炎:病例报告及文献复习。
Ann Palliat Med. 2021 Jul;10(7):8460-8466. doi: 10.21037/apm-21-23. Epub 2021 May 12.
5
Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review.卡瑞利珠单抗相关的致命性免疫相关性肝炎伴肝内胆汁淤积及肺炎:一例病例报告及文献复习
Open Med (Wars). 2021 Apr 7;16(1):553-557. doi: 10.1515/med-2021-0267. eCollection 2021.
6
Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors.与免疫检查点抑制剂相关的颅神经疾病。
Neurology. 2021 Feb 9;96(6):e866-e875. doi: 10.1212/WNL.0000000000011340. Epub 2020 Dec 14.
7
Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade.接受 CTLA-4 和 PD-1/PD-L1 检查点阻断治疗的患者的神经眼科并发症。
J Neuroophthalmol. 2021 Dec 1;41(4):519-530. doi: 10.1097/WNO.0000000000001148.
8
Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes.免疫检查点抑制剂相关性葡萄膜炎:治疗方法和结果的综述。
Ocul Immunol Inflamm. 2021 Jan 2;29(1):203-211. doi: 10.1080/09273948.2020.1781902. Epub 2020 Aug 20.
9
Central nervous system complications associated with immune checkpoint inhibitors.与免疫检查点抑制剂相关的中枢神经系统并发症。
J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):772-778. doi: 10.1136/jnnp-2020-323055. Epub 2020 Apr 20.
10
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.免疫检查点抑制剂的严重神经毒性:不断扩大的范围。
Ann Neurol. 2020 May;87(5):659-669. doi: 10.1002/ana.25708. Epub 2020 Mar 10.